Skip to main content
大禹生物 logo

大禹生物 — Investor Relations & Filings

Ticker · 920970 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 384 across all filing types
Latest filing 2022-09-01 Transaction in Own Shar…
Country CN China
Listing Beijing Stock Exchange 920970

About 大禹生物

http://www.sxdysw.cn/

Shanxi Dayu Biological Assistance Co., Ltd. specializes in the research, development, and production of advanced animal nutrition and health solutions. The company focuses on the manufacturing of feed additives, micro-ecological preparations, and biological feed products. Its core portfolio includes probiotics, enzyme preparations, and functional premixes designed to enhance livestock immunity, improve feed conversion rates, and promote sustainable farming practices. By leveraging biotechnology, the firm provides integrated solutions for the aquaculture and animal husbandry sectors, emphasizing scientific innovation and product quality to support the modernization of the agricultural supply chain.

Recent filings

Filing Released Lang Actions
回购进展情况公告
Transaction in Own Shares Classification · 95% confidence The document is a public announcement regarding the progress of a share repurchase (buyback) plan by the company 山西大禹生物工程股份有限公司. It details the repurchase plan's approval, purpose, method, price limits, quantity, funding source, and implementation period. It also provides an update on the repurchase progress as of a specific date. The content is focused on the company's own shares repurchase activity, not a financial report or other type of filing. Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length is short and it is not an announcement of a report publication but a substantive update on the repurchase itself, supporting a high confidence classification.
2022-09-01 Chinese
独立董事关于第三届董事会第五次会议相关事项的独立意见
Board/Management Information Classification · 95% confidence The document is an independent directors' opinion on a board meeting matter, specifically regarding the company's use of raised funds. It references a special report on the use of raised funds but does not contain the report itself. The document is short (541 characters) and serves as an official opinion or statement related to board matters. It is not a full financial report, audit, or earnings release. The content aligns with Board/Management Information (MANG) as it relates to board meeting opinions and governance matters.
2022-08-22 Chinese
第三届监事会第四次会议决议公告
Report Publication Announcement Classification · 95% confidence The document is a resolution announcement from the Supervisory Board (监事会) of Shanxi Dayu Bioengineering Co., Ltd. It details the meeting date, attendance, and the approval of two agenda items: the 2022 semi-annual report and a special report on the use of raised funds. However, the document itself does not contain the actual semi-annual report or financial data but refers readers to the Beijing Stock Exchange website for the full reports (with announcement numbers 2022-076 and 2022-077). The document is short (978 characters) and serves as a formal announcement of meeting resolutions rather than the report itself. According to the "Menu vs Meal" rule, this is a Report Publication Announcement (RPA) rather than an Interim/Quarterly Report (IR) or Annual Report (10-K).
2022-08-22 Chinese
2022年半年度报告
Interim / Quarterly Report Classification · 95% confidence The document is titled as a "半年度报告" which translates to "Half-Year Report" or Interim Report for the year 2022. It contains detailed financial data including income, expenses, assets, liabilities, profit and loss, and operational analysis for the period January 1, 2022 to June 30, 2022. The document includes comprehensive financial statements and management discussion of business conditions and risks. It explicitly states it is unaudited but provides substantive financial data and analysis for a period shorter than a full fiscal year. This matches the definition of an Interim / Quarterly Report (IR). The document is about 15,000 characters long, which is consistent with a full report rather than a brief announcement or certification. Therefore, the correct classification is IR with high confidence. H1 2022
2022-08-22 Chinese
2022年半年度报告披露提示性公告
Report Publication Announcement Classification · 100% confidence The document is a short announcement (327 characters) indicating that the company's 2022 half-year report and summary have been published on the official exchange platform. It does not contain the actual financial data or report content but directs investors to where the report can be found. According to the 'MENU VS MEAL' rule, this is a Report Publication Announcement (RPA), not the interim report itself.
2022-08-22 Chinese
第三届董事会第五次会议决议公告
Board/Management Information Classification · 95% confidence The document is a formal announcement of resolutions passed at the fifth meeting of the third board of directors of Shanxi Dayu Biological Engineering Co., Ltd. It includes details about the meeting's time, place, attendance, and voting results on specific agenda items. The agenda items include approval of the company's 2022 semi-annual report and a special report on the use of raised funds, but the document itself does not contain the reports or detailed financial data. Instead, it references these reports as being disclosed elsewhere (on the Beijing Stock Exchange website). The document is primarily about board meeting decisions and resolutions, not the reports themselves. Therefore, it fits best under the category of Board/Management Information (MANG), which covers announcements of changes or decisions by the board of directors.
2022-08-22 Chinese

Browse filings by year

5 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.